UNIVERSITY OF WASHINGTON

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1861-01-01

Employees: 10K

Market Cap: -

Website: https://www.cs.washington.edu

Clinical Trials

Use of Passive, Adaptive, and Active Prosthetic Knees in Persons With Unilateral, Transfemoral Amputation

Not Applicable

Completed

Conditions: Transfemoral Amputation

Interventions: Device: Active knee (Ossur Power Knee II)
Device: Adaptive knee (Ossur Rheo)
Device: Passive knee (Various manufacturers)

First Posted Date: 2014-08-18

Last Posted Date: 2015-12-28

Lead Sponsor: University of Washington

Target Recruit Count: 12

Registration Number: NCT02219230

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

TWILIGHT Study: Effect of Light Exposure During Acute Rehabilitation on Sleep After TBI

Not Applicable

Completed

Conditions: Traumatic Brain Injury
TBI
Sleep

Interventions: Device: Red Light (RL)
Device: Bright White Light (BWL)

First Posted Date: 2014-08-12

Last Posted Date: 2021-11-09

Lead Sponsor: University of Washington

Target Recruit Count: 131

Registration Number: NCT02214212

Locations: 🇺🇸
Harborview Medical Center, Seattle, Washington, United States

Ultrasound Imaging of Kidney Stones and Lithotripsy

Not Applicable

Not yet recruiting

Conditions: Kidney Stones
Urolithiasis
Ureter Stones
Nephrolithiasis

Interventions: Device: Verasonics Data Acquisition System (VDAS)

First Posted Date: 2014-08-12

Last Posted Date: 2025-03-27

Lead Sponsor: University of Washington

Target Recruit Count: 370

Registration Number: NCT02214836

Locations: 🇺🇸
University of Washington, Department of Urology, Seattle, Washington, United States

Ibrutinib in Treating Patients With Relapsed or Refractory Transformed Indolent B-cell Non-Hodgkin Lymphoma

Phase 2

Completed

Conditions: Recurrent Transformed B-Cell Non-Hodgkin Lymphoma
Refractory Transformed B-Cell Non-Hodgkin Lymphoma

Interventions: Drug: Ibrutinib
Other: Laboratory Biomarker Analysis

First Posted Date: 2014-08-01

Last Posted Date: 2025-01-07

Lead Sponsor: University of Washington

Target Recruit Count: 20

Registration Number: NCT02207062

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Proton Beam Re-Irradiation in Thoracic Cancers

Not Applicable

Completed

Conditions: Recurrent Disease
Thoracic Neoplasm
Metastatic Malignant Neoplasm in the Lung

Interventions: Radiation: Proton Beam Radiation Therapy

First Posted Date: 2014-07-30

Last Posted Date: 2018-11-20

Lead Sponsor: University of Washington

Target Recruit Count: 6

Registration Number: NCT02204761

Locations: 🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States
🇺🇸
ProCure Proton Therapy Center-Seattle, Seattle, Washington, United States

An Open Label Trial of Stribild for Antiretroviral (ARV)-naïve HIV-2 Infected Adults in Dakar, Senegal

Phase 4

Completed

Conditions: HIV-2 Infection

Interventions: Drug: Stribild (Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF) 1 tablet daily X 48 weeks

First Posted Date: 2014-07-02

Last Posted Date: 2018-07-26

Lead Sponsor: University of Washington

Target Recruit Count: 30

Registration Number: NCT02180438

Locations: 🇸🇳
Clinique des Maladies Infectieuses Ibrahima DIOP Mar/CRCF, Centre Hospitalier Universitaire de Fann, Dakar, Senegal

Carbon-11 Acetate and Fluorine F 18 Sodium Fluoride PET as a Biomarker of Treatment Response in Patients With Hormone Resistant Metastatic Prostate Cancer

Not Applicable

Withdrawn

Conditions: Hormone-resistant Prostate Cancer
Recurrent Prostate Cancer
Stage IV Prostate Cancer

Interventions: Radiation: carbon-11 acetate
Radiation: fluorine F 18 sodium fluoride
Procedure: positron emission tomography
Other: laboratory biomarker analysis

First Posted Date: 2014-06-20

Last Posted Date: 2016-08-31

Lead Sponsor: University of Washington

Registration Number: NCT02169063

Locations: 🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States

18F-FLT PET/CT in Measuring Cell Proliferation in Patients With Brain Tumors

Not Applicable

Completed

Conditions: Primary Brain Neoplasm
Metastatic Malignant Neoplasm in the Brain
Recurrent Brain Neoplasm

Interventions: Procedure: Computed Tomography
Radiation: Fluorothymidine F-18
Procedure: Positron Emission Tomography

First Posted Date: 2014-06-18

Last Posted Date: 2020-01-13

Lead Sponsor: University of Washington

Target Recruit Count: 9

Registration Number: NCT02167204

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Evaluation of Metabolic Acid-base Abnormalities in Pre-eclamptic Women Applying the Stewart-Fencl Approach

Completed

Conditions: Mild Pre-eclampsia
Severe Pre-eclampsia

First Posted Date: 2014-06-16

Last Posted Date: 2014-10-15

Lead Sponsor: University of Washington

Target Recruit Count: 120

Registration Number: NCT02164370

Locations: 🇿🇦
University of Cape Town, Cape Town, Western Cape, South Africa
🇺🇸
University of Washington, Seattle, Washington, United States

Treatment of Chronic Post-Traumatic Headache With OnabotulinumtoxinA

Phase 3

Terminated

Conditions: Chronic Post Traumatic Headache

Interventions: Drug: OnabotulinumtoxinA

First Posted Date: 2014-06-10

Last Posted Date: 2018-10-23

Lead Sponsor: University of Washington

Target Recruit Count: 13

Registration Number: NCT02160535

Locations: 🇺🇸
University of Washington Headache Clinic, Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy